AbbVie Inc. Comprehensive Income 2011-2026 | ABBV
Beta
What is comprehensive income?
Comprehensive income includes net income plus other comprehensive items like foreign currency adjustments and unrealized investment gains or losses.
What is AbbVie Inc.'s current comprehensive income?
AbbVie Inc. (ABBV) annual comprehensive income for 2025 was $5.01B, a 7.46% increase from 2024. AbbVie Inc. comprehensive income for the quarter ending March 31, 2026 was $686.0M.
What was AbbVie Inc.'s comprehensive income in 2024?
AbbVie Inc. annual comprehensive income for 2024 was $4.67B, a 2.12% decline from 2023.
What was AbbVie Inc.'s comprehensive income in 2023?
AbbVie Inc. annual comprehensive income for 2023 was $4.77B, a 62.00% decline from 2022.
What is AbbVie Inc.'s 5-year comprehensive income CAGR?
AbbVie Inc. comprehensive income grew at a compound annual growth rate (CAGR) of 0.34% from FY2020 to FY2025, going from $5.10B to $5.01B over 5 years.
Comprehensive Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-0.3%
FY2020
$5.10B
→
FY2025
$5.01B
111213141516171819202122232425
5 years selected
Comprehensive Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $5.01B | +7.5% | 10-K |
| FY2024 | $4.67B | -2.1% | 10-K |
| FY2023 | $4.77B | -62.0% | 10-K |
| FY2022 | $12.54B | +6.6% | 10-K |
| FY2021 | $11.77B | +130.7% | 10-K |
| FY2020 | $5.10B | -24.6% | 10-K |
| FY2019 | $6.77B | +14.0% | 10-K |
| FY2018 | $5.93B | +14.8% | 10-K |
| FY2017 | $5.17B | -12.8% | 10-K |
| FY2016 | $5.93B | +28.5% | 10-K |
| FY2015 | $4.61B | +2394.1% | 10-K |
| FY2014 | $185.0M | -96.1% | 10-K |
| FY2013 | $4.70B | -10.4% | 10-K |
| FY2012 | $5.25B | +68.1% | 10-K |
| FY2011 | $3.12B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →